Seeing Arthritis Earlier: The Search for Answers Before Damage Begins
Ask anyone living with arthritis how their diagnosis happened, and you’ll often hear the same story: a swollen joint here, an ache that wouldn’t go away there, months of wondering what it meant. By the time many people finally get an answer, inflammation has already left its mark—stiffness that won’t fully resolve, joints that never […]
The 2026 ANRF Impact Report Is Here
Decades of discovery. A model that works. And the science that comes next. Arthritis and autoimmune disease research doesn’t announce itself. It builds — through questions asked in early-career labs, through grants awarded before the world knows a scientist’s name, through discoveries that take decades to reach the treatments patients rely on today. The ANRF […]
ANRF Announces Largest Scholar Cohort and Research Investment in Foundation History
As demand for independent research funding reaches an all-time high, the Arthritis National Research Foundation answers with its largest cohort, its biggest financial commitment, and a class of scientists tackling some of the most urgent questions in rheumatology today. More than 54 million Americans live with arthritis. Millions more are navigating lupus, scleroderma, psoriatic arthritis, […]
Immune Boost Capital Appoints Dr. Sai Nandi to Head Impact Investment Fund Targeting Immune-Mediated Diseases
Veteran biotech investor to steer IBC’s impact fund targeting early-stage therapies, diagnostics, and technologies for immune disorders. Immune Boost Capital (IBC), the newly formed venture fund of the Arthritis National Research Foundation (ANRF), today announced that Dr. Sai Nandi has joined the firm as Fund Principal. In this capacity, Dr. Nandi will lead the expansion of […]
60 Minutes to Save Millions
This year, more scientists applied for arthritis and autoimmune disease research funding than at any point in the Arthritis National Research Foundation’s 50-year history. It means that right now, more brilliant early-career researchers are ready to pursue ideas that could change what it means to live with these conditions, affecting more than 60 million adults […]
Arthritis National Research Foundation Appoints Schalon Newton, DBA, as Principal of Immune Boost Capital
Industry Veteran to Lead New Philanthropic Venture Fund Addressing Critical Early-Stage Funding Gap in Autoimmune Therapeutics and Diagnostics The Arthritis National Research Foundation (ANRF), a leading nonprofit funder of early-stage autoimmune disease research, announced the appointment of Schalon Newton, DBA, as Principal of Immune Boost Capital (IBC), its newly formed philanthropic evergreen venture fund. IBC […]